The therapy of primary adult systemic CD30-positive anaplastic large cell lymphoma: Results of 40 cases treated in a single center

Leukemia and Lymphoma

Volumn 35, Issue 1-2, 1999, Pages 159-169

  Fanin, Renato ^a   Sperotto, Alessandra ^a   Silvestri, Federico ^a   Cerno, Michela ^a   Geromin, Antonella ^a   Stocchi, Raffaella ^a   Infanti, Laura ^a   Patriarca, Francesca ^a   Zaja, Francesco ^a   Damiani, Daniela ^a   Baccarani, Michele ^a  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

Adults; Anaplastic large cell lymphoma; Primary systemic CD30+ lymphoma; Therapy

Indexed keywords

CARMUSTINE; CD30 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LARGE CELL LYMPHOMA; MALE; MULTIMODALITY CANCER THERAPY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION; VEIN THROMBOSIS;

EID: 0032829274     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909145715     Document Type: Article

References (42)

1. Schwab, U., Stein, H. Gerdes, J., Lemke, H., Kirchner, H., Schaadt, M. and Diehl, V. (1982). Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature, 299, 65-7.
2. Stein, H., Gerties, J., Schwab, U., Lemke, H., Mason, D.Y., Ziegler, A., Schienle, W. and Diehl, V. (1982). Identification of Hodgkin and Sternberg-Reed cells as a unique cell type derived from a newly-detected small cell population. Int J Cancer., 30, 445-51.
3. Stein, H., Mason, D.Y., Gerdes, J., O'Connor, N., Wainscoat, J., Pallesen, G., Gatter, K., Falini, B., Delsol, G., Lemke, H., Schwarting, R., and Lennert, K. (1985). The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood, 66, 848-58.
4. Stein, H., Gerds, J., Tippelmann, G., Dienemann, D., Schwarting, R., O'Connor, N., Pileri, S., Pallesen, G. and Delsol, G. (1987). Ki-1 lymphoma: experience and clinical findings. Third Internaltional Conference on Malignant Lymphoma, Lugano, Switzerland. June 10-3 (abstr).
5. Kadin, M.E. (1994). Primary Ki-1-positive anaplastic large-cell lymphoma: a distinct clinicopathologic entity. Ann Oncol., 5, S25-S30.
6. Agnarsson, B.N. and Kadin, E.D. (1988). Ki-1 positive large cell lymphoma. Am J Surg Pathol., 12, 264-274.
7. Stansfeld, A.C., Diebold, J., Kapanci, V., Kelenyi, G., Lannert, K., Mioduszewska, O., Noel, H., Rielke, F., Sundstrom, C., Van Unnik, J.A.M., and Wright, H.D. (1988). Updated Kiel Classification for lymphomas. Lancet, 1, 292-3.
8. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K.C., Clearly, M.L., Delsol, G., De Wolf-Peelers, C., Falini, B., Gatter, K.C., Grogan, T.M., Isaacson, P.G., Knowles, D.M., Mason, D.Y., Muller-Hermelink, H.K., Pileri, S., Piris, M.A., Ralfkaier, E. and Warnke, R.A. (1994). A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood, 34, 1361-92.
9. Pileri, S., Falini, B., Delsol, G., Stein, H., Baglioni, P., Poggi, S., Martelli, M.F., Rivano, M.T., Mason, D.Y. and Stansfeld, A.G. (1990). Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1 with a high content of reactive histiocytes). Histopathology, 16, 383-91.
10. Stein, H., Herbst, H., Anagnostopoulos, I. (1991). The nature of Hodgkin and Reed-Steinberg cells, their association with EBV, and their relationship to anaplastic large cell lymphoma. Ann Oncol., 2, 33-8.
11. Morris, S.W., Kirsten, M.N., Valentine, M.B., Dittmer, K.G., Shapiro, D.N., Saltman, D.L. and Look, A.T. (1994). Fusion of a kinase gene ALK, to a nucleolar protein gene. NPM, in non Hodgkin's lymphoma. Science, 263, 1281-4.
12. Pileri, S., Bocchia, M., Baroni, C.D., Martelli, M., Falini, B., Sabattini, E., Gherlinzoni, F., Amadori, S., Poggi, S., Mazza, P., Burgio, V., Zinzani, P.L., Melilli, G., Benni, M., Saragoni, L., Martelli, M.F., Stein, H., Mandelli, F. and Tura, S. (1994). Anaplastic large cell lymphoma (CD30+Ki-1+): results of a prospective clinico-pathological study of 69 cases. Brit J Haematol., 86, 513-23.
13. Mason, D.Y., Bastard, C., Rimokh, R., Dastugue, N., Huret, J.L., Kristofferson, U., Magaud, J.P., Nezelof, C., Tilly, H., Vannier, J.P., Hemet, J. and Warnke, R. (1990). CD30 positive cell lymphomas (Ki1 lymphomas) are associated with a chromosomal translocation involving 5q35. Br J Haematol., 74, 161-8.
14. Lamant, L., Meggetto, F., Al Saati Brugnieres, L., Bressac de Paillerets, B., Dastugue, N., Berbinheim, A., Rubie, H., Terrier-Lacombe, M.J., Robert, A., Brousset, P., Rigal, F., Schlaifer, D., Shirota, M., Mori, S. and Delsol, G. (1996). High incidence of the t(2:5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. Blood, 87, 284-91.
15. Sarris, A.H., Luthra, R., Papadimitracopoulou, V., Waasdorp, M., Meletios, A., Dimopoulos, J.A., McBride, J.A., Cabanillus, F., Duvic, M., Deisseroth, A., Morris, S.W. and Pugh, W.C. (1996). Amplification of genomic DNA demonstrates the presence of the t(2:5)(p23:q35) in anaplastic large cell lymphoma, but not other non-Hodgkin's lymphomas. Hodgkin's disease, or lymphomatoid papulosis. Blood, 88, 1771-9.
16. Rosso, R., Paulli, M., Magrini, U., Kindl, S., Boveri, E., Volpato, G., Poggi, S., Baglioni, P. and Pileri, S. (1989). Anaplastic large cell lymphoma. CD30/Ki-1 positive, expressing the CD15/Leu-M1 antigen. Virchows Arch B., 416, 229-32.
17. Engelhard, M., Brittinger, G., Huhn, D., Gerhartz, H.H., Meusers, P., Siegert, W., Thiel, E., Wilmanss, W., Aydermir, U., Bierwolf, S., Griesser, H., Tiemann, M., and Lennert, K. (1997). Subclassification of diffuse large B-cell lymphomas according to the Kiel Classification: distinction of centroblastic and immunoblastic lyrnphomas is a significant prognostic risk factor. Blood, 89, 2291-7.
18. Zinzani, P.L., Bendandi, M., Martelli, M., Falini, B., Sabattini, E., Amadori, S., Gherlinzoni, F., Martelli, M.F., Mandelli, F., Tura, S. and Pileri, S.A. (1996). Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients. J Clin Oncol., 14, 955-62.
19. Filippa, D.A., Ladanyi, M., Wollner, N., Straus, D.J., O'Brien, J.P., Portlock, C., Gangi, M. and Sun, M. (1996). CD30 (Ki-1)-positive malignant lymphomas: clinical, immunophenotypic, histologic, and genetic characteristics and differences with Hodgkin's disease. Blood, 87, 2905-17.
20. Tilly, H., Gaulard, P., Lepage, E., Dumontet, C., Diebold, J., Plantier, I., Berger, R., Symann, M., Petrella, T., Lederlin, P. and Briere, J. (1997). Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood, 90, 3727-34.
21. Fanin, R., Silvestri, F., Geromin, A., Cerno, M., Infanti, L., Zaja, F., Barillari, G., Savignano, C., Rinaldi, C., Damiani, D., Buffoli, A., Biffoni, F. and Baccarani, M. (1996). Primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma of the adult: sequential intensive treatment with F-MACHOP regimen (± radiotherapy) and autologous bone marrow transplantation. Blood, 87, 1243-8.
22. Fanin, R., Silvestri, F., Geromin A. Cerno, M., Infanti, L., Zaja, F., Barillari, G., Savignano, C., Rinaldi, C., Damiani, D., Buffoli, A., Biffoni, F. and Baccarani, M. (1997). Sequential intensive treutment with the F-MACHOP regimen (± radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma in adults. Leuk Lymph., 24, 369-77.
23. Fanin, R., Silvestri, F. (1996). Therapy of primary systemic CD30-positive anaplastic large cell lymphoma of the adult. J Clin Oncol., 14, 3049-51.
24. Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., Carbone, P.P. (1982). Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol., 5, 649-55.
25. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's Lymphoma. (1993). N Engl J Med., 329, 987-94.
26. Zaja, F., Russo, D., Silvestri, F., Fanin, R., Infanti L., Bendini M., Zuiani C., Englaro E., Englaro E., and Guerra, P. (1995). Computed Tomography. Magnetic Resonance and Gallium 67 Scintigraphy for the imaging of residual lymphoma. Haematologica, 80, 59-71.
27. Infanli, L., Silvestri, F., Fanin, R., Salmaso, F., Zaja, F., Barillari, G., Patriarca, F., Geromin, A., Cerno, M., Damiani, D and Baccarani, M. (1996). The F-MACHOP regimen in the treatment of aggressive Non-Hodgkin's Lymphomas: a single centre experience in 72 patients. Haematologica, 81, 521-8.
28. Chan, J.K.C., Ng, C.S., Hui, P.K., Leung, T.W., Lo, E.S.F., Lau, W.H. and McGuire, L.J. (1989). Anaplastic large cell Ki-1 lymphoma. Delineation of two morphological types. Histopathol., 15, 11-34.
29. Tashiro, K., Kikuchi, M., Takeshita, M., Yoshida, T. and Ohshima, K. (1989). Clinicopathological Study of Ki-1 positive lymphomas. Path Res Pract., 185, 461-7.
30. Chou, A., Kaserer, K., Augustin, I., Vesely, M., Heinz, R., Oehilinger, W., Hanak, H. and Radaszkiewicz, T. (1990). Ki-1-positive large cell lymphoma. A clinicopathologic study of 41 cases. Am J Surg Path., 14(5), 439-48.
31. Nakamura, S., Takagi, N., Kojima, M., Motoori, T., Kitoh, K., Osada, H., Suzuki, H., Ogura, M., Kurita, S., Oyama, A., Ueda., R., Takahashi, T. and Suchi, R. (1991). Clinicopathologic study of large cell anaplastic lymphoma (Ki-1-positive large cell lymphoma) among the Japanese. Cancer, 68, 118-29.
32. Penny, R.J., Blaustein, J.C., Longtine, A.J. and Geraldine, S.P. (1991). Ki-1-positive large cell lymphomas, a heterogenous group of neoplasms. Morphologic, immunophenotypic, genotypic and clinical features of 24 cases. Cancer, 68, 362-373.
33. Greer, J.P., Kinney, M.C., Collins, R.D., Saalhany, K.E., Wolff, S.N., Hainsworth, J.D., Flexner, J.M. and Stein, R.S. (1991). Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J Clin Oncol. 9, 539-47.
34. De Bruin, P.C., Beljaards, R.C., Van Heerde, P., Van Der Valk, P., Noorduyn, L.A., Van Krieken, J.H.J.M., Kluin-Nelernans, J.C., Willemze, R. and Meijer, C.J.L.M. (1993). Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype. Histopathol., 23, 127-35.
35. Shulman, L.N., Frisard, B., Antin, J.H., Wheeler, C., Pinkus, G., Magauran, N., Mauch, P., Nobles, E., Mashal, R., Canellos, G., Tung, N. and Kadin, M. (1993). Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome. J Clin Oncol., 11, 937-42.
36. Romaguera, J.E., Manning, J.T., Tornos, C.S., Rodriguez, J., Brooks, T.E., Pugh, W.C., Ordonez, N.G., Goodacre, A.M. and Cabanillas, F. (1994). Long term prognostic importance of primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large-cell lymphoma. Ann Oncol., 5, 317-22.
37. Tirelli, U., Vaccher, E., Zagonel, V., Talamini, R., Bernardi, D., Tavio, M., Gloghini, A., Merola, A.C., Monfardini, S. and Carbone, A. (1995). CD30 (ki-1)-positive anaplastic large-cell lymphomas in 13 patients with and 27 patients without human immunodeficiency virus infection: the first comparative clinicopathologic study from a single institution that also includes 80 patients with other human immunodeficiency virus-related systemic lymphomas. J Clin Oncol., 13, 373-80.
38. Longo, G., Federico, M., Pieresca, C., Avanzini, P., Iannitto, E., Di Frisco, A.U., Baldini, L., Brugiatelli, M., Clò, V., Bevini, M. and Silingardi, V. (1995). Anaplastic large cell lymphoma (CD30+Ki-1+). Analysis of 35 cases followed at GISL centres. Eur J Cancer., 310A, 1763-7.
39. Clavio, M., Rossi, E., Truini, M., Truini, M., Carrara, P., Ravetti, J.L., Spriano, M., Vimercati, A.R., Santini, G., Canepa, L., Pierri, I., Celesti, L., Miglino, M., Castellaneta, A., Damasio, E. and Gobbi, M. (1996). Anaplastic large cell lymphonia: a clinicopathologic study of 53 patients. Leuk Lymph., 22, 319-27.
40. Zinzani P.L., Martelli M., Magagnoli., Zaccaria A., Ronconi F., Cantonetti., Bocchia M., Marra R., Gobbi M., Falini B., Gherlinzoni F., Moretti L., De Renzo A., Mazza P., Pavone E., Sabattini E., Amendola A., Bendandi M., Pileri SA., Mandelli F., Tura S. (1998). Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy. Blood, 92, 790-794.
41. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma. (1997). Blood, 89, 3909-18.
42. Gisselbrecht C., Gaulard P., Lepage E., Coiffier B., Briere J., Haioun C., Cazals-Hatem D., Bosly A., Xerri L., Tilly H., Berger F., Bouhabdallah R., Diebold J., for the Groupe d'Etudies des Lymphomes de l'Adulte (GELA). (1998). Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Blood, 92, 76-82.